REQUEST A DEMO
Total
USD $0.00
Search more companies

Sagittarius Life Science Corp. (Taiwan, China)

Main Activities: Chemical Manufacturing
Full name: Sagittarius Life Science Corp. Profile Updated: May 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company was set up in March 1998. In July 2001, the company's products Saxobin (Doxazosinmesylate) tablets2mg was agreed for future reference by the Department of Health. Ref: DOH drug No. 0900039817. In October 2001, the company's products anti-osteoporosis drugs SO101C received grants the leading new product development from Industrial Development Bureau Ministry of Economic Affairs. In March 2002, the company products dementia long-term treatment of percutaneous absorption patch SA201D was patented by U.S. Patent numbers: US6352715B103/05/02. In April 2002, the company MG103 R & D results were published in Journal of Cellular Biochemistry 84 : 532-544 (2002 ). In August 2002, its shares went though public offering. In September 2002, anti-osteoporosis medicine SO101C was approved by Department of Health and granted formal entry into Phase II human clinical trials.

Headquarters
10F-6, No.3,Yuanqu St., Nangang District
Taipei City; Taipei City;

Contact Details: Purchase the Sagittarius Life Science Corp. report to view the information.

Website: http://www.naturalbiokey.com

Basic Information
Total Employees:
Purchase the Sagittarius Life Science Corp. report to view the information.
Outstanding Shares:
Purchase the Sagittarius Life Science Corp. report to view the information.
Financial Auditors:
Purchase the Sagittarius Life Science Corp. report to view the information.
Incorporation Date:
March 16, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
9.62%
Purchase this report to view the information.
0.61%
Purchase this report to view the information.
0.47%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Green Tree Resources Limited (United Kingdom)
100%
Le Neau Limited (Samoa)
100%
壹康生物科技股份有限公司
100%
Company Performance
Financial values in the chart are available after Sagittarius Life Science Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
2.71%
Total operating revenue
3.46%
Operating profit (EBIT)
-0.83%
EBITDA
-34.45%
Net Profit (Loss) for the Period
-3.18%
Total assets
16.95%
Total equity
18.89%
Operating Profit Margin (ROS)
0.24%
Net Profit Margin
-0.05%
Return on Equity (ROE)
0.78%
Quick Ratio
-0.67%
Cash Ratio
-0.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?